• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CKS2过表达与肺腺癌预后及免疫细胞浸润的相关性:一项基于生物信息学和实验的综合研究

CKS2 Overexpression Correlates with Prognosis and Immune Cell Infiltration in Lung Adenocarcinoma: A Comprehensive Study based on Bioinformatics and Experiments.

作者信息

Wang Zhiping, Zhang Mengyan, Wu Yahua, Yu Yilin, Zheng Qunhao, Li Jiancheng

机构信息

Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, Fujian, China.

出版信息

J Cancer. 2021 Oct 11;12(23):6964-6978. doi: 10.7150/jca.63625. eCollection 2021.

DOI:10.7150/jca.63625
PMID:34729099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8558665/
Abstract

Cyclin-dependent kinase regulatory subunit 2 (CKS2) plays a vital role in regulation of the cell cycle and cancer progression. However, the role of CKS2 in lung adenocarcinoma (LUAD) remains unkonwn. Here, we examined the prognostic value and biological functions of CKS2 in LUAD by using omics data of 1,235 LUAD samples from TCGA, GEO, and our own cohort as well as data of experiments. Kaplan-Meier was conducted to evaluate the prognostic value of CKS2 expression. The association between CKS2 expression level and tumor immune infiltration was explored using the single-sample Gene Set Enrichment Analysis (ssGSEA) and TIMER database. Functional enrichment analyses were performed to annotate the biological functions of CKS2 in LUAD. Furthermore, a series of experiments and immunohistochemistry were performed for validation. CKS2 overexpression was correlated with the advanced stage, TP53 status, PD-L1 expression, and DNA hypomethylation. Moreover, patients with LUAD and high CKS2 expression exhibited poor overall survival. Functional enrichment analysis indicated that CKS2 was involved in cell division, cell cycle, DNA replication. Experiments indicated that CKS2 knockdown decreased the invasion and proliferation of LUAD cells and facilitated their apoptosis. ssGSEA and TIMER analysis revealed a negative correlation between CKS2 expression and the immune cell infiltration In summary, High CKS2 expression was associated with poor prognosis and low levels of infiltrating immune cells in LUAD as well as with malignant phenotypes. Therefore, CKS2 may be a promising prognostic biomarker and therapeutic target in LUAD.

摘要

细胞周期蛋白依赖性激酶调节亚基2(CKS2)在细胞周期调控和癌症进展中起着至关重要的作用。然而,CKS2在肺腺癌(LUAD)中的作用仍不清楚。在此,我们通过使用来自TCGA、GEO以及我们自己队列的1235例LUAD样本的组学数据以及实验数据,研究了CKS2在LUAD中的预后价值和生物学功能。采用Kaplan-Meier法评估CKS2表达的预后价值。使用单样本基因集富集分析(ssGSEA)和TIMER数据库探讨CKS2表达水平与肿瘤免疫浸润之间的关联。进行功能富集分析以注释CKS2在LUAD中的生物学功能。此外,还进行了一系列实验和免疫组织化学以进行验证。CKS2过表达与晚期、TP53状态、PD-L1表达和DNA低甲基化相关。此外,LUAD且CKS2高表达的患者总生存期较差。功能富集分析表明CKS2参与细胞分裂、细胞周期和DNA复制。实验表明,敲低CKS2可降低LUAD细胞的侵袭和增殖并促进其凋亡。ssGSEA和TIMER分析显示CKS2表达与免疫细胞浸润呈负相关。总之,高CKS2表达与LUAD的不良预后、低浸润免疫细胞水平以及恶性表型相关。因此,CKS2可能是LUAD中一个有前景的预后生物标志物和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/2430b5a7dd8d/jcav12p6964g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/330a27f4efd1/jcav12p6964g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/151c9a333810/jcav12p6964g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/f7ab992c085a/jcav12p6964g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/41ea7261a328/jcav12p6964g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/9da72a7196d3/jcav12p6964g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/d83c6eaf7385/jcav12p6964g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/b3be6875900d/jcav12p6964g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/2430b5a7dd8d/jcav12p6964g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/330a27f4efd1/jcav12p6964g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/151c9a333810/jcav12p6964g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/f7ab992c085a/jcav12p6964g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/41ea7261a328/jcav12p6964g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/9da72a7196d3/jcav12p6964g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/d83c6eaf7385/jcav12p6964g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/b3be6875900d/jcav12p6964g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ba/8558665/2430b5a7dd8d/jcav12p6964g008.jpg

相似文献

1
CKS2 Overexpression Correlates with Prognosis and Immune Cell Infiltration in Lung Adenocarcinoma: A Comprehensive Study based on Bioinformatics and Experiments.CKS2过表达与肺腺癌预后及免疫细胞浸润的相关性:一项基于生物信息学和实验的综合研究
J Cancer. 2021 Oct 11;12(23):6964-6978. doi: 10.7150/jca.63625. eCollection 2021.
2
Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.SEC61G 在肺腺癌中的预后价值:基于生物信息学和体外验证的综合研究。
BMC Cancer. 2021 Nov 13;21(1):1216. doi: 10.1186/s12885-021-08957-4.
3
Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma.未被苯并咪唑 1 过表达抑制的芽殖与不良预后和恶性表型相关:肺腺癌有希望的治疗靶点。
Thorac Cancer. 2023 Apr;14(10):893-912. doi: 10.1111/1759-7714.14822. Epub 2023 Feb 24.
4
Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.综合分析确定GNG7作为肺腺癌中与免疫浸润相关的预后生物标志物。
Front Genet. 2022 Sep 9;13:984575. doi: 10.3389/fgene.2022.984575. eCollection 2022.
5
Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity.细胞周期蛋白依赖性激酶亚单位 2(CKS2)作为 I-III 期浸润性非黏液性肺腺癌的预后标志物及其对药物敏感性的影响。
Cells. 2022 Aug 22;11(16):2611. doi: 10.3390/cells11162611.
6
LncRNA-AC068228.1 Is a Novel Prognostic Biomarker That Promotes Malignant Phenotypes in Lung Adenocarcinoma.长链非编码RNA-AC068228.1是一种新型的预后生物标志物,可促进肺腺癌的恶性表型。
Front Oncol. 2022 Feb 23;12:856655. doi: 10.3389/fonc.2022.856655. eCollection 2022.
7
AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.AUNIP表达与免疫浸润相关,是肝细胞癌和肺腺癌的候选诊断及预后生物标志物。
Front Oncol. 2020 Dec 9;10:590006. doi: 10.3389/fonc.2020.590006. eCollection 2020.
8
High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma.CKS2 高表达预示不良结局:胶质瘤潜在的治疗靶点。
Front Immunol. 2022 May 19;13:881453. doi: 10.3389/fimmu.2022.881453. eCollection 2022.
9
High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformation.高SGO2预示肺腺癌预后不良且具有较高治疗价值,并促进细胞增殖、迁移、侵袭及上皮-间质转化。
J Cancer. 2023 Jul 24;14(12):2301-2314. doi: 10.7150/jca.86285. eCollection 2023.
10
Serves as a Potential Prognostic Marker and Correlates with Immune Infiltration in Lung Adenocarcinoma.作为一种潜在的预后标志物,与肺腺癌中的免疫浸润相关。
Int J Gen Med. 2022 Mar 8;15:2727-2745. doi: 10.2147/IJGM.S340565. eCollection 2022.

引用本文的文献

1
Pareto task inference analysis reveals cellular trade-offs in diffuse large B-Cell lymphoma transcriptomic data.帕累托任务推理分析揭示了弥漫性大B细胞淋巴瘤转录组数据中的细胞权衡。
Front Syst Biol. 2024 Mar 1;4:1346076. doi: 10.3389/fsysb.2024.1346076. eCollection 2024.
2
DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression.DNMT1阻断SOX21抑制的CKS2转录以促进胃癌进展。
BMC Cancer. 2025 Jul 17;25(1):1182. doi: 10.1186/s12885-025-14577-z.
3
Upregulation of CKS2 in immunosuppressive cells is associated with metastasis and poor prognosis in prostate cancer: a single-cell RNA-sequencing analysis.

本文引用的文献

1
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.癌症免疫疗法的历史与进展:了解肿瘤浸润免疫细胞的特征及其治疗意义。
Cell Mol Immunol. 2020 Aug;17(8):807-821. doi: 10.1038/s41423-020-0488-6. Epub 2020 Jul 1.
2
The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization.SMART 应用程序:用于全面 DNA 甲基化分析和可视化的交互式网络应用程序。
Epigenetics Chromatin. 2019 Dec 5;12(1):71. doi: 10.1186/s13072-019-0316-3.
3
Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
免疫抑制细胞中CKS2的上调与前列腺癌的转移和不良预后相关:一项单细胞RNA测序分析
Transl Cancer Res. 2024 Aug 31;13(8):3996-4009. doi: 10.21037/tcr-23-2100. Epub 2024 Aug 27.
4
Biological functions and therapeutic potential of CKS2 in human cancer.CKS2在人类癌症中的生物学功能及治疗潜力
Front Oncol. 2024 Aug 12;14:1424569. doi: 10.3389/fonc.2024.1424569. eCollection 2024.
5
Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment.CKS2在肝细胞癌中的表达:与生存结果及免疫微环境的相关性
J Hepatocell Carcinoma. 2023 Oct 9;10:1767-1784. doi: 10.2147/JHC.S427624. eCollection 2023.
6
Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity.细胞周期蛋白依赖性激酶亚单位 2(CKS2)作为 I-III 期浸润性非黏液性肺腺癌的预后标志物及其对药物敏感性的影响。
Cells. 2022 Aug 22;11(16):2611. doi: 10.3390/cells11162611.
7
CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis.CKS2 和 S100A12:类风湿关节炎的两个新型诊断生物标志物。
Dis Markers. 2022 Jun 25;2022:2431976. doi: 10.1155/2022/2431976. eCollection 2022.
8
LINC01578 affects the radiation resistance of lung cancer cells through regulating microRNA-216b-5p/TBL1XR1 axis.LINC01578 通过调控 microRNA-216b-5p/TBL1XR1 轴影响肺癌细胞的辐射抵抗能力。
Bioengineered. 2022 Apr;13(4):10721-10733. doi: 10.1080/21655979.2022.2051881.
细胞周期蛋白依赖性激酶调节亚基 2 预示着肝癌不良预后并促进其侵袭性表型。
Dis Markers. 2019 Oct 22;2019:8964015. doi: 10.1155/2019/8964015. eCollection 2019.
4
CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.CKS2 促进肿瘤进展和转移,是上皮性卵巢癌不良预后的独立预测因子。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3225-3234. doi: 10.26355/eurrev_201904_17681.
5
Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.CKS2 的过表达与不良预后相关,并促进乳腺癌细胞的增殖和侵袭。
Mol Med Rep. 2019 Jun;19(6):4761-4769. doi: 10.3892/mmr.2019.10134. Epub 2019 Apr 5.
6
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Metascape 为系统水平数据集的分析提供了面向生物学家的资源。
Nat Commun. 2019 Apr 3;10(1):1523. doi: 10.1038/s41467-019-09234-6.
7
PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.PD-1/PD-L1 阻断疗法在晚期非小细胞肺癌中的应用:现状与未来方向。
Oncologist. 2019 Feb;24(Suppl 1):S31-S41. doi: 10.1634/theoncologist.2019-IO-S1-s05.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
Role of mTOR Signaling in Tumor Microenvironment: An Overview.mTOR 信号在肿瘤微环境中的作用:概述。
Int J Mol Sci. 2018 Aug 19;19(8):2453. doi: 10.3390/ijms19082453.
10
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells.肺癌:分子特征、克隆异质性与进化以及癌症干细胞
Cancers (Basel). 2018 Jul 27;10(8):248. doi: 10.3390/cancers10080248.